Press Releases

Date	Title and Summary	Additional Formats
Nov 02, 2023	Standard BioTools to Present at the Jefferies London Healthcare Conference SOUTH SAN FRANCISCO, Calif. , Nov. 02, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –  Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm , PhD, will give a presentation
Oct 25, 2023	Standard BioTools Announces Conference Call and Webcast of Third Quarter 2023 Financial Results on November 7, 2023 SOUTH SAN FRANCISCO, Calif. , Oct. 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –  Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2023 financial results on Tuesday, November 7, 2023,
Oct 04, 2023	Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights Expands commercial reach with substantial
Aug 08, 2023	Standard BioTools Reports Second Quarter 2023 Financial Results Continued operational execution improves revenue growth, margin expansion, and expense reduction SOUTH SAN FRANCISCO, Calif. , Aug. 08, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) (“Standard BioTools”, or the “Company”), driven by a bold purpose – Unleashing tools to accelerate
Jul 26, 2023	Standard BioTools to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif. , July 26, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced Company management will participate in the following investor conferences: Canaccord
Jul 25, 2023	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2023 Financial Results SOUTH SAN FRANCISCO, Calif. , July 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –  Unleashing tools to accelerate breakthroughs in human health – today announced that it will report second quarter 2023 financial results on Tuesday, August 8, 2023, after
Jun 14, 2023	Standard BioTools to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif. , June 14, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced Company management will participate in the following investor conferences: Capital One
May 25, 2023	Standard BioTools to Present at the Jefferies Healthcare Conference SOUTH SAN FRANCISCO, Calif. , May 25, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm , PhD, will give a presentation at
May 18, 2023	Standard BioTools Announces NGS Library Preparation as an Upgrade on the X9 High-Throughput Genomics System Supporting discovery through screening, the X9 is the only system integrating real-time PCR and NGS library preparation SOUTH SAN FRANCISCO, Calif. , May 18, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose –  Unleashing tools to accelerate breakthroughs in
May 15, 2023	Standard BioTools Appoints Jeffrey Black as Chief Financial Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif. , May 15, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing